News
H.R. 471 Approved by House Energy and Commerce Committee
February 12, 2015
ARLINGTON, Va. — HDMA President and CEO John M. Gray issued the following statement following the House Energy and Commerce Committee’s approval of the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (H.R. 471). The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif).
“HDMA is delighted that H.R. 471 has cleared another milestone toward House passage. We thank Chairman Upton, the House Energy and Commerce Committee and the bill sponsors for their commitment to strengthening the relationship between pharmaceutical supply chain and regulatory stakeholders to help reduce prescription drug abuse and diversion.”
ABOUT HDA
HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.
